Markets:

Overview

News

Currencies

International

Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

235.41 -3.65 (-1.52%)

Streaming Delayed Price Updated: 3:15 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

IQVIA Beats Q1 Earnings Expectations Despite Sector Uncertainty, Company Navigating Market Conditions 'Effectively' Says CEO ↗

May 06, 2025

IQVIA reports Q1 EPS of $2.70 and revenue of $3.83 billion, raises 2025 sales outlook and highlights strong growth in analytics and R&D pipeline metrics.

Via Benzinga

Wondering what's happening in today's S&P500 pre-market session? ↗

May 06, 2025

Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics.

Via Chartmill

IQVIA (NYSE:IQV) Beats Q1 Sales Targets, Full-Year Sales Guidance is Optimistic

May 06, 2025

Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue...

Via StockStory

IQVIA Reports First-Quarter 2025 Results

May 06, 2025

From IQVIA Holdings Inc.

Via Business Wire

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

IQVIA (IQV) Q1 Earnings Report Preview: What To Look For

May 05, 2025

Clinical research company IQVIA (NYSE: IQV) will be reporting earnings tomorrow before the bell. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again? ↗

May 01, 2025

Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?

Via Investor's Business Daily

Topics Animal Testing Economy Government

Tuesday's pre-market session: top gainers and losers in the S&P500 index ↗

April 29, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.

Via Chartmill

IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards

April 28, 2025

From IQVIA

Via Business Wire

Beyond The Numbers: 12 Analysts Discuss IQVIA Hldgs Stock ↗

April 25, 2025

Via Benzinga

Get insights into the top movers in the S&P500 index of Friday's pre-market session. ↗

April 25, 2025

Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.

Via Chartmill

3 Healthcare Stocks That Concern Us

April 25, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

Via StockStory

Topics Stocks

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm

April 23, 2025

From IQVIA

Via Business Wire

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

April 21, 2025

From IQVIA

Via Business Wire

Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report

April 15, 2025

From IQVIA Holdings Inc.

Via Business Wire

Alphabet To $185? Here Are 10 Top Analyst Forecasts For Thursday ↗

April 10, 2025

Via Benzinga

These S&P500 stocks have an unusual volume in today's session ↗

April 09, 2025

Curious about which S&P500 stocks are generating unusual volume on Wednesday? Find out below.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

April 09, 2025

Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

March 31, 2025

Curious about the market action on Monday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

March 26, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest...

Via StockStory

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

March 25, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers.

Via StockStory

3 Reasons IQV is Risky and 1 Stock to Buy Instead

March 19, 2025

IQVIA’s stock price has taken a beating over the past six months, shedding 22.2% of its value and falling to $190.42 per share. This may have investors wondering how to approach the situation.

Via StockStory

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

March 18, 2025

Let’s dig into the relative performance of Fortrea (NASDAQ:FTRE) and its peers as we unravel the now-completed Q4 drug development inputs & services earnings season.

Via StockStory

10 Health Care Stocks Whale Activity In Today's Session ↗

March 11, 2025

Via Benzinga

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

March 11, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Repligen (NASDAQ:RGEN) and...

Via StockStory

IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services

March 10, 2025

From IQVIA

Via Business Wire

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

March 05, 2025

Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.

Via StockStory

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

March 04, 2025

From IQVIA

Via Business Wire

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor ↗

February 25, 2025

Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.

Via Benzinga

IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence

February 24, 2025

From IQVIA

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.